These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31086594)

  • 1. miR-219-3p regulates the occurrence of hepatic fibrosis by targeting Smad2.
    Yin W; Zhang W; Zhu Y; Ni H; Gong L; Fu M
    Exp Ther Med; 2019 Jun; 17(6):4635-4642. PubMed ID: 31086594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-142-3p inhibits high-glucose-induced endothelial-to-mesenchymal transition through targeting TGF-β1/Smad pathway in primary human aortic endothelial cells.
    Zhu GH; Li R; Zeng Y; Zhou T; Xiong F; Zhu M
    Int J Clin Exp Pathol; 2018; 11(3):1208-1217. PubMed ID: 31938215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of miR-143-3p contributes to the anti-fibrosis effect of atorvastatin on myocardial tissues via the modulation of Smad2 activity.
    Yu B; Yu M; Zhang H; Xie D; Nie W; Shi K
    Exp Mol Pathol; 2020 Feb; 112():104346. PubMed ID: 31758917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling.
    Qiao B; Cai JH; Lam AK; He BX
    Oncotarget; 2017 Sep; 8(41):70761-70776. PubMed ID: 29050317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression.
    Wei S; Wang Q; Zhou H; Qiu J; Li C; Shi C; Zhou S; Liu R; Lu L
    Mol Ther Nucleic Acids; 2019 Jun; 16():758-769. PubMed ID: 31150929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory Effect of Corilagin on miR-21-Regulated Hepatic Fibrosis Signaling Pathway.
    Zhou X; Xiong J; Lu S; Luo L; Chen ZL; Yang F; Jin F; Wang Y; Ma Q; Luo YY; Wang YJ; Zhou JB; Liu P; Zhao L
    Am J Chin Med; 2019; 47(7):1541-1569. PubMed ID: 31752524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
    He Y; Huang C; Sun X; Long XR; Lv XW; Li J
    Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
    Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W
    Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression.
    Wang Q; Wei S; Zhou H; Li L; Zhou S; Shi C; Shi Y; Qiu J; Lu L
    Front Cell Dev Biol; 2020; 8():513. PubMed ID: 32637414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.
    Cui H; Banerjee S; Xie N; Ge J; Liu RM; Matalon S; Thannickal VJ; Liu G
    Am J Respir Cell Mol Biol; 2016 Jun; 54(6):843-52. PubMed ID: 26600197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-β1/Smad signaling pathway.
    Wu SP; Yang Z; Li FR; Liu XD; Chen HT; Su DN
    Exp Ther Med; 2017 Sep; 14(3):2568-2576. PubMed ID: 28962196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
    Zou M; Wang F; Gao R; Wu J; Ou Y; Chen X; Wang T; Zhou X; Zhu W; Li P; Qi LW; Jiang T; Wang W; Li C; Chen J; He Q; Chen Y
    Sci Rep; 2016 Apr; 6():24747. PubMed ID: 27098600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
    Ai K; Zhu X; Kang Y; Li H; Zhang L
    Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-β1/Smad signaling pathway.
    Cheng B; Zhu Q; Lin W; Wang L
    Exp Ther Med; 2019 Jan; 17(1):284-290. PubMed ID: 30651793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway
    Yang F; Luo L; Zhu ZD; Zhou X; Wang Y; Xue J; Zhang J; Cai X; Chen ZL; Ma Q; Chen YF; Wang YJ; Luo YY; Liu P; Zhao L
    Front Pharmacol; 2017; 8():929. PubMed ID: 29311932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.